Processa Pharmaceuticals, Inc. Earnings Per Share, Basic and Diluted
Processa Pharmaceuticals, Inc. (PCSA) reported Earnings Per Share, Basic and Diluted of -$0.75 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-30
- Processa Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.19.
- Processa Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.20.
- Processa Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.14.
- Processa Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.55.
- Processa Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2021 was -$0.75.
- Processa Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2020 was -$2.54.
- Processa Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2019 was -$0.70.
- Processa Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2018 was -$0.71.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed | Earnings Per Share, Basic and Diluted 27 month | Earnings Per Share, Basic and Diluted 30 month | Earnings Per Share, Basic and Diluted 36 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$0.75 10-K · filed 2022-03-30 | ||||||||||
| 2021-09-30 | -$0.19 10-Q · filed 2021-11-12 | -$0.54 10-Q · filed 2021-11-12 | |||||||||
| 2021-06-30 | -$0.20 10-Q · filed 2021-08-12 | -$0.35 10-Q · filed 2021-08-12 | |||||||||
| 2021-03-31 | -$0.14 10-Q · filed 2021-05-13 | ||||||||||
| 2020-12-31 | -$2.54 10-K · filed 2022-03-30 | ||||||||||
| 2020-09-30 | -$0.55 10-Q · filed 2021-11-12 | -$0.84 10-Q · filed 2021-11-12 | |||||||||
| 2020-06-30 | -$0.13 10-Q · filed 2021-08-12 | -$0.29 10-Q · filed 2021-08-12 | |||||||||
| 2020-03-31 | -$0.16 10-Q · filed 2021-05-13 | ||||||||||
| 2019-12-31 | -$0.70 10-K · filed 2021-03-25 | ||||||||||
| 2019-09-30 | -$0.16 10-Q · filed 2020-11-12 | -$0.02 10-Q · filed 2019-11-14 | -$0.47 10-Q · filed 2020-11-12 | -$0.07 10-Q · filed 2019-11-14 | |||||||
| 2019-06-30 | -$0.18 10-Q · filed 2020-08-05 | -$0.03 10-Q · filed 2019-08-14 | -$0.31 10-Q · filed 2020-08-05 | -$0.04 10-Q · filed 2019-08-14 | |||||||
| 2019-03-31 | -$0.14 10-Q · filed 2020-05-15 | -$0.02 10-Q · filed 2019-05-14 | |||||||||
| 2018-12-31 | -$0.71 10-K · filed 2020-03-06 | -$0.10 10-K · filed 2019-03-28 | |||||||||
| 2018-09-30 | -$0.02 10-Q · filed 2019-11-14 | -$0.09 10-Q · filed 2019-11-14 | |||||||||
| 2018-06-30 | -$0.03 10-Q · filed 2019-08-14 | -$0.06 10-Q · filed 2019-08-14 | |||||||||
| 2018-03-31 | -$0.03 10-Q · filed 2019-05-14 | ||||||||||
| 2017-12-31 | -$0.02 10-K · filed 2018-04-16 | -$0.06 10-K/A · filed 2019-04-08 | |||||||||
| 2017-09-30 | -$0.02 10-Q · filed 2018-11-14 | -$0.01 derived: net income ÷ weighted average shares · filed 2018-11-14 | -$0.04 10-Q · filed 2018-11-14 | -$0.03 10-Q · filed 2017-11-20 | -$0.01 derived: net income ÷ weighted average shares · filed 2018-11-14 | ||||||
| 2017-06-30 | -$0.01 10-Q · filed 2018-08-14 | $0.00 10-Q · filed 2017-10-04 | -$0.02 10-Q · filed 2018-08-14 | -$0.01 10-Q · filed 2017-10-04 | -$0.01 derived: net income ÷ weighted average shares · filed 2018-08-14 | -$0.01 derived: net income ÷ weighted average shares · filed 2018-08-14 | |||||
| 2017-03-31 | -$0.01 10-Q · filed 2018-05-21 | -$0.01 derived: net income ÷ weighted average shares · filed 2018-05-21 | -$0.01 derived: net income ÷ weighted average shares · filed 2018-05-21 | -$0.01 derived: net income ÷ weighted average shares · filed 2018-05-21 | |||||||
| 2016-12-31 | -$0.01 10-K · filed 2018-04-16 | -$0.01 derived: net income ÷ weighted average shares · filed 2018-04-16 | -$0.01 derived: net income ÷ weighted average shares · filed 2018-04-16 | -$0.07 10-K · filed 2018-04-16 | -$0.03 10-K · filed 2017-09-25 | ||||||
| 2016-09-30 | -$0.03 10-K · filed 2018-04-16 | -$0.01 10-Q · filed 2017-09-08 | -$0.00 derived: net income ÷ weighted average shares · filed 2018-04-16 | -$0.03 10-Q · filed 2017-11-20 | -$0.02 10-Q · filed 2017-09-08 | -$0.03 derived: net income ÷ weighted average shares · filed 2018-04-16 | |||||
| 2016-06-30 | -$0.02 10-K · filed 2018-04-16 | -$0.01 10-Q · filed 2017-08-30 | -$0.02 10-Q · filed 2017-10-04 | -$0.03 derived: net income ÷ weighted average shares · filed 2018-04-16 | -$0.05 derived: net income ÷ weighted average shares · filed 2018-04-16 | ||||||
| 2016-03-31 | -$0.01 10-K · filed 2018-04-16 | -$0.03 derived: net income ÷ weighted average shares · filed 2018-04-16 | -$0.05 derived: net income ÷ weighted average shares · filed 2018-04-16 | -$0.19 derived: net income ÷ weighted average shares · filed 2018-04-16 | |||||||
| 2015-12-31 | -$0.03 derived: net income ÷ weighted average shares · filed 2017-09-25 | -$0.06 derived: net income ÷ weighted average shares · filed 2017-09-25 | -$0.25 derived: net income ÷ weighted average shares · filed 2017-09-25 | -$0.31 10-K · filed 2017-09-25 | |||||||
| 2015-09-30 | -$0.03 10-Q · filed 2017-09-08 | -$0.21 derived: net income ÷ weighted average shares · filed 2017-09-08 | -$0.27 10-Q · filed 2017-09-08 | -$0.55 derived: net income ÷ weighted average shares · filed 2017-09-08 | |||||||
| 2015-06-30 | -$0.19 10-Q · filed 2017-08-30 | -$0.24 10-Q · filed 2017-08-30 | -$0.25 10-Q · filed 2015-08-19 | -$0.52 derived: net income ÷ weighted average shares · filed 2017-08-30 | -$0.64 derived: net income ÷ weighted average shares · filed 2017-08-30 | ||||||
| 2015-03-31 | -$0.06 10-Q · filed 2017-08-07 | -$0.33 derived: net income ÷ weighted average shares · filed 2017-08-07 | -$0.45 derived: net income ÷ weighted average shares · filed 2017-08-07 | -$0.56 derived: net income ÷ weighted average shares · filed 2017-08-07 | |||||||
| 2014-12-31 | -$0.28 derived: net income ÷ weighted average shares · filed 2017-06-19 | -$0.40 derived: net income ÷ weighted average shares · filed 2017-06-19 | -$0.52 derived: net income ÷ weighted average shares · filed 2017-06-19 | -$0.68 10-K · filed 2017-06-19 | |||||||
| 2014-09-30 | -$0.10 10-Q · filed 2015-12-01 | -$0.21 derived: net income ÷ weighted average shares · filed 2015-12-01 | -$0.37 10-Q · filed 2015-12-01 | -$0.45 derived: net income ÷ weighted average shares · filed 2015-12-01 | |||||||
| 2014-06-30 | -$0.11 10-Q · filed 2015-08-19 | -$0.27 10-Q · filed 2015-08-19 | -$0.35 derived: net income ÷ weighted average shares · filed 2015-08-19 | -$0.47 derived: net income ÷ weighted average shares · filed 2015-08-19 | |||||||
| 2014-03-31 | -$0.17 10-Q · filed 2015-05-15 | -$0.24 derived: net income ÷ weighted average shares · filed 2015-05-15 | -$0.36 derived: net income ÷ weighted average shares · filed 2015-05-15 | -$0.56 derived: net income ÷ weighted average shares · filed 2015-05-15 | -$2.26 10-Q · filed 2014-05-14 | ||||||
| 2013-12-31 | -$0.07 derived: net income ÷ weighted average shares · filed 2015-04-14 | -$0.19 derived: net income ÷ weighted average shares · filed 2015-04-14 | -$0.38 derived: net income ÷ weighted average shares · filed 2015-04-14 | -$0.61 10-K · filed 2015-04-14 | |||||||
| 2013-09-30 | -$0.12 10-Q · filed 2014-11-13 | -$0.34 derived: net income ÷ weighted average shares · filed 2014-11-13 | -$0.62 10-Q · filed 2014-11-13 | -$1.01 derived: net income ÷ weighted average shares · filed 2014-11-13 | -$2.15 10-Q · filed 2013-11-08 | ||||||
| 2013-06-30 | -$0.34 10-Q · filed 2014-08-19 | -$0.79 10-Q · filed 2014-08-19 | -$1.29 derived: net income ÷ weighted average shares · filed 2014-08-19 | -$1.69 derived: net income ÷ weighted average shares · filed 2014-08-19 | -$2.36 10-Q/A · filed 2013-09-06 | ||||||
| 2013-03-31 | -$0.48 10-Q · filed 2014-05-14 | -$0.96 derived: net income ÷ weighted average shares · filed 2014-05-14 | -$1.36 derived: net income ÷ weighted average shares · filed 2014-05-14 | -$1.68 derived: net income ÷ weighted average shares · filed 2014-05-14 | |||||||
| 2012-12-31 | -$0.48 derived: net income ÷ weighted average shares · filed 2014-03-27 | -$0.88 derived: net income ÷ weighted average shares · filed 2014-03-27 | -$1.19 derived: net income ÷ weighted average shares · filed 2014-03-27 | -$1.50 10-K · filed 2014-03-27 | |||||||
| 2012-09-30 | -$0.40 10-Q · filed 2013-11-08 | -$0.71 derived: net income ÷ weighted average shares · filed 2013-11-08 | -$1.02 10-Q · filed 2013-11-08 | ||||||||
| 2012-06-30 | -$0.31 10-Q/A · filed 2013-09-06 | -$0.63 10-Q/A · filed 2013-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |